Except for TP53, there were only two genes with mutation rates greater than 75%, IPH1 (77%) in brain lower grade glioma (LGG) and KRAS (90%) in pancreatic adeno‐carcinoma (PAAD). This evidence concerns the gene KRAS and pancreatic adenocarcinoma.